Combination therapy with savolitinib and osimertinib shows promising results in treating advanced NSCLC with EGFR mutations ...

Immunohistochemistry is the primary option, as long as the cases classified as 2+ or equivocal are re-evaluated by in situ hybridization. Mechanisms of EGFR upregulation are dependent on the ...

This could make KRAS-mutated colon cancer more treatable than previously thought. Our results show that EGFR, a receptor on the cell surface of many cells, also plays an active role in KRAS ...

ISLAMABAD: In a major development, Islamabad High Court (IHC) has stopped the Federal Board of Revenue (FBR) from immediate tax recovery against taxpayers under the controversial Tax Laws ...

The COCOON regimen significantly reduced dermatologic side effects and improved quality of life in EGFR-mutated NSCLC patients treated with amivantamab and lazertinib. Patients receiving COCOON DM ...

The patients in the study had progressed following treatment with a third-generation EGFR tyrosine kinase inhibitor (TKI). The HARMONi trial readout (PDF) marks the fourth phase 3 study result for ...